OR WAIT null SECS
Patricia Van Arnum was executive editor of Pharmaceutical Technology.
June 02, 2008
Antibody drug conjugates offer a niche opportunity in drug development and contract manufacturing.
May 29, 2008
The US Senate approved a measure (HR 2642) that would provide the US Food and Drug Administration with $275 million in additional funding under a supplemental appropriations bill. The measure now goes before the House.
May 20, 2008
The European Federation of Pharmaceutical Industries and Associations (EFPIA), the trade association representing European pharmaceutical manufacturers, issued recommendations to the public consultation launched in March by the European Commission's proposed drug anticounterfeiting measures. EFPIA's proposal includes a ban on drug repackaging.
May 15, 2008
Eli Lilly completed the final and largest phase of a major biotechnology expansion in Indianapolis, Indiana.
May 09, 2008
Increased investment by the pharmaceutical and biotechnology majors in offshore early drug development creates opportunities and challenges for outsourcing.
Congress is considering proposing a new chemical policy similar to the European Union’s REACH (Registration, Evaluation, Authorization, and Restriction of Chemicals) regulation. Batch and custom manufacturers weigh in on the debate.